Advertisement

Topics

More good news for AZ with priority review for non-Hodgkin’s lymphoma drug

08:04 EDT 2 Aug 2017 | thePharmaLetter

Following yesterday’s news that the US Food and Drug Administration had granted breakthrough status…

Original Article: More good news for AZ with priority review for non-Hodgkin’s lymphoma drug

NEXT ARTICLE

More From BioPortfolio on "More good news for AZ with priority review for non-Hodgkin’s lymphoma drug"

Quick Search
Advertisement